SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731

Hematologic malignancy is a risk factor for severe coronavirus disease 2019 (COVID‐19) in adults; however, data specific to children with leukemia are limited. High‐quality infectious adverse event data from the ongoing Children's Oncology Group (COG) standard‐risk B acute lymphoblastic leukemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Elgarten, Caitlin W., Kairalla, John A., Thompson, Joel C., Miller, Tamara P., Wang, Cindy, Conway, Susan, Loh, Mignon L., Raetz, Elizabeth A., Gupta, Sumit, Rau, Rachel E., Angiolillo, Anne, Rabin, Karen R., Alexander, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435702/
https://www.ncbi.nlm.nih.gov/pubmed/37601850
http://dx.doi.org/10.1002/jha2.697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435702/
https://www.ncbi.nlm.nih.gov/pubmed/37601850
http://dx.doi.org/10.1002/jha2.697

Ejemplares similares